Assessing the Efficacy and Safety of an 11ß-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2196/resprot.7806
PubMed Identifier: 28923789
Publication URI: http://europepmc.org/abstract/MED/28923789
Type: Journal Article/Review
Volume: 6
Parent Publication: JMIR research protocols
Issue: 9
ISSN: 1929-0748